← All organizations

3D Medicines

For profitWebsite ↗

Also known as: 3D Medicines | 3D Medicines (Beijing) Co., Ltd. | 3D Medicines (Sichuan) Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 15, 2023

Timeline

2010s

Jun 1, 2010
3D Medicines— Founded

Drugs by trial phase (14 distinct, 18 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

anlotinib

Indications

Studied for

Recent trials (19)

NCT06123754Lead sponsorPhase 3Dec 15, 2023
NCT05849311Lead sponsorPhase 1May 29, 2023
NCT05265052Lead sponsorPhase 2Sep 30, 2022
NCT05320809Lead sponsorPhase 1Aug 1, 2022
NCT05039892Lead sponsorPhase 2Jun 30, 2022
NCT04910386Lead sponsorPhase 2Jun 1, 2022
NCT05218759CollaboratorN/AFeb 21, 2022
NCT05112991Lead sponsorPhase 2Jan 31, 2022
NCT05099536Lead sponsorPhase 1Dec 31, 2021
NCT05024214Lead sponsorPhase 1/Phase 2Nov 30, 2021
NCT04891198Lead sponsorPhase 2Aug 6, 2021
NCT04941313Lead sponsorPhase 1Jul 27, 2021
NCT04221204Study directorPhase 1Sep 1, 2019
NCT04221204Lead sponsorPhase 1Sep 1, 2019
NCT03667170Lead sponsorPhase 2Aug 22, 2018

Details

Founded: Minhang, CN Jun 1, 2010
Last known activity: Dec 15, 2023